series-b
Stage
2018
Founded
4
Investors
About
Aurealis Therapeutics develops multi-target cell and gene therapies focused on treating chronic wounds, cancers, and inflammatory diseases using a proprietary platform to modulate tissue microenvironments.
Explore Aurealis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.